NIFTY 500 › Financial Services
Overview Technical Risk & rank Filings Guidance & governance
Filings
39 filings of STARHEALTH since January 2025.
presentation 13, board outcome 10, transcript 8, results 6, credit rating 2
| Filed | Type | Subject | |
|---|---|---|---|
| 31 Oct 2026 | transcript Guidance, Legal, Results | Star Health And Allied Insurance Company Limited has informed the Exchange about TranscriptAI summaryStar Health and Allied Insurance filed the transcript of its Q2 & H1 FY2027 earnings call held on October 28, 2026. Management reported Q2 gross written premium (1/n basis) up 19% year-on-year to Rs. 5,275 crore and H1 up 19% to Rs. 9,562 crore; Q2 underwriting result of Rs. 99 crore versus a loss of Rs. 40 crore a year earlier. Management reported Q2 profit after tax of Rs. 265 crore (versus Rs. 80 crore) and H1 PAT up 57% year-on-year to Rs. 815 crore; combined insurance service ratio improved to 98% in Q2 and 97.9% in H1. Management described the underwriting turnaround as structural and said it enters H2 "from a position of strength and confidence", while noting that headline growth rates will moderate as the GST-led base effect comes in from Q3. Management welcomed IRDAI's proposed distribution reforms and Public Insurance Registry, and said it has submitted views on the consultation paper and awaits final regulations. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 27 Oct 2026 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed its earnings call investor presentation for Q2 and H1 FY27 (quarter and half year ended September 30, 2026), to be presented on October 28, 2026 at 8:30 A.M. IST. H1 FY27 Gross Written Premium (reported, 1/N basis) was ₹9,562 Cr, up 19% YoY; retail fresh GWP was ₹1,630 Cr, up 36% YoY. H1 FY27 Profit After Tax was ₹815 Cr versus ₹518 Cr in H1 FY26; Q2 FY27 PAT was ₹265 Cr versus ₹80 Cr in Q2 FY26. H1 FY27 Combined Insurance Service Ratio was 97.9% (H1 FY26: 100.3%) and underwriting result was ₹210 Cr (H1 FY26: ₹(24) Cr). Investment income for H1 FY27 was ₹911 Cr, up 21% YoY; shareholder net worth stood at ₹10,436 Cr as of September 30, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 27 Oct 2026 | results Results | Star Health and Allied Insurance Company Limited has informed the exchanges regarding Integrated filing (Financial) of the Company for the quarter and half year ended September 30, 2026AI summaryStar Health and Allied Insurance Company Limited filed its integrated financial filing (Annexure 1) for the quarter and half year ended September 30, 2026, under SEBI, BSE and NSE circulars. The filing includes income statement, segment results (Health, Personal Accident, Travel, Reinsurance) and IRDAI analytical ratios such as claims ratio and expense ratio. Reported figures are partly illegible in the OCR text, so specific revenue and profit amounts cannot be reliably stated from these pages. The filing states the information is also hosted on the company website, www.starhealth.in. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 27 Oct 2026 | board outcome Legal, Results | Star Health and Allied Insurance Company Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.AI summaryStar Health and Allied Insurance's board approved the unaudited standalone financial results for the quarter and half year ended September 30, 2026, with a limited review report from joint statutory auditors T R Chadha & Co LLP and MSKA & Associates LLP. The board also approved reclassification of Sthitaprajna Advisors LLP from the Promoter Group category to the Public Shareholder category. The board meeting ran from 11:30 A.M. to 6:30 P.M. (IST) on October 27, 2026. The OCR text of the results tables is partly garbled, so specific revenue and profit figures are not reliably readable and are not stated here. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 01 Oct 2026 | credit rating Rating | Star Health And Allied Insurance Company Limited has informed the Exchange about Credit RatingAI summaryStar Health and Allied Insurance Company Limited filed intimation of rating reaffirmation dated October 01, 2026. India Ratings and Research Private Limited, via website disclosure dated September 28, 2026, affirmed the issuer rating at AA+ with a Stable outlook. The subordinate debt rating was affirmed at AA with a Stable outlook. The company stated the intimation was inadvertently delayed due to operational exigencies. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2026 | transcript Guidance, Results | Star Health and Allied Insurance Company Limited has informed the Exchange about transcripts of the Earnings Call dated July 30, 2026AI summaryStar Health and Allied Insurance filed the earnings call transcript for its Q1 FY2027 call held July 30, 2026, per its letter dated August 5, 2026. Management reported gross return premium (1/N basis) up 19% YoY to Rs. 4,287 crore; on N basis Rs. 4,672 crore, up 19% YoY. Management said the Q1 underwriting result was Rs. 111 crore versus Rs. 16 crore in Q1 FY26, and CISR improved to 97% from 98.7%. Management said profit after tax rose 25% YoY to Rs. 550 crore, and normalised PAT (at 8% normalised investment yield) rose 44% YoY to Rs. 386 crore. Management said retail market share was 29% in Q1 FY27 versus 31% in Q1 FY26, and that it expects insurance revenue growth to gradually rise toward 15-16%. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jul 2026 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed its Q1 FY27 earnings call investor presentation, to be made to investors and analysts on July 30, 2026 at 8.30 A.M. IST for the quarter ended June 30, 2026. Q1 FY27 gross written premium (reported, 1/N basis) was ₹4,287 Cr, up 19% YoY; retail fresh GWP was ₹730 Cr, up 37% YoY. Q1 FY27 underwriting result was ₹111 Cr versus ₹16 Cr in Q1 FY26; CISR improved to 97.0% from 98.7%. Q1 FY27 profit after tax was ₹550 Cr versus ₹438 Cr in Q1 FY26, up 25%; reported post-tax ROE was 22.3% annualised. Q1 FY27 normalised PAT (at 8% normalised investment yield) was ₹386 Cr versus ₹267 Cr; normalised ROE was 15.6% annualised. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jul 2026 | board outcome Acquisition, Dividend / buy-back, Results | Star Health and Allied Insurance Company Limited has submitted to the Exchange, the standalone limited reviewed financial results for the quarter ended Jun 30, 2026.AI summaryStar Health and Allied Insurance Company Limited's board approved unaudited standalone financial results for the quarter ended June 30, 2026, with a limited review report from joint statutory auditors T R Chadha & Co LLP and MSKA & Associates LLP. The board approved reclassification of certain shareholders from the Promoter / Promoter Group category to the Public category, subject to stock exchange and member approvals. The board approved exercise of call option and redemption in full of 4,000 unsecured redeemable convertible NCDs (interest due September 30, 2026) and 700 unsecured redeemable convertible NCDs (interest due October 29, 2026). The board meeting ran from 11:30 A.M. to 05.20 P.M. (IST) on July 29, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 26 Jun 2026 | board outcome Acquisition, Management change | Star Health and Allied Insurance Company Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 26, 2026.AI summaryBoard of Star Health and Allied Insurance met on June 26, 2026 (4:30 PM to 4:45 PM IST) and approved the retirement of Independent Directors Rajeev Krishnamuralilal Agarwal and Rajni Sekhri Sibal, effective close of business on July 15, 2026, after five consecutive years' tenure. The Board approved transmission of 8,28,82,958 equity shares held by the late Rakesh Jhunjhunwala, per a Bombay High Court probate dated December 18, 2023. Utpal Sheth resigned as Nominee Director of the late Rakesh Jhunjhunwala effective June 26, 2026, following withdrawal of nomination by the estate. Utpal Hemendra Sheth was appointed Additional Director (Non-Executive) representing promoter Sitara Partners LLP, subject to member approval, following IRDAI approval dated April 06, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 May 2026 | transcript Guidance, Results | Star Health and Allied Insurance Company Limited has informed the Exchange about Transcript of the Earnings Call dated April 29, 2026AI summaryStar Health and Allied Insurance filed the transcript of its Q4 & FY2026 earnings call held April 29, 2026. Management said Q4 FY26 gross written premium rose 17% YoY on N basis to Rs. 6,259 crore, with underwriting profit of Rs. 186 crore and a combined ratio of 95.7%; the company reported a Q4 loss of Rs. 55 crore due to a Rs. 558 crore mark-to-market loss. For FY26, management said GWP rose 16% YoY on N basis to Rs. 20,369 crore, underwriting profit was Rs. 206 crore, and PAT was Rs. 911 crore; on a normalized 8% investment yield basis, PAT was Rs. 1,222 crore and ROE was 13.1%. Management said it expects loss ratio improvement to continue and remains confident of sustainable growth and ROE balance into FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2026 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed a revised earnings call presentation for Q4 and FY2026 (results for the quarter and year ended March 31, 2026), following its April 28, 2026 intimation. FY26 Normalised PAT (IND AS) was ₹1,222 Cr versus ₹840 Cr in FY25; reported PAT (IND AS) was ₹911 Cr versus ₹787 Cr, up 16% YoY. FY26 GWP ('n' basis) was ₹20,369 Cr versus ₹17,488 Cr in FY25; retail fresh GWP was ₹4,567 Cr, up 9% YoY. FY26 combined ratio (IND AS) was 98.8% versus 101.1% in FY25; underwriting profit was ₹206 Cr versus a loss of ₹165 Cr in FY25. FY26 persistency (renewal ratio) was 91% and overall company NPS was 62. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Apr 2026 | presentation Guidance, Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed its investor presentation for Q4 and FY2026 results, to be made to investors and analysts on April 29, 2026 at 8.30 A.M. IST. FY26 normalised PAT was ₹1,222 crore versus ₹840 crore in FY25; reported PAT was ₹911 crore versus ₹787 crore; FY26 GWP (n basis) was ₹17,488 crore versus ₹20,369 crore in FY25 (down about 16% YoY per the slide labels). FY26 combined ratio (Ind AS) was 98.8% versus 101.1% in FY25; underwriting profit was ₹206 crore versus a loss of ₹165 crore. Q4 FY26 reported PAT was a loss of ₹55 crore versus a profit of ₹271 crore in Q4 FY25; Q4 FY26 investment income was -₹230 crore, including marked-to-market losses of ₹558 crore. FY26 persistency (renewal ratio) was 91% and proprietary channels contributed 91% of retail fresh business. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Apr 2026 | board outcome Results | Star Health and Allied Insurance Company Limited has submitted to the Exchange, the standalone audited financial results for the quarter and financial year ended March 31, 2026.AI summaryStar Health and Allied Insurance Company Limited's board met on April 28, 2026 and approved the audited standalone financial results for the quarter and year ended March 31, 2026, with an unmodified audit opinion from joint statutory auditors T R Chadha & Co LLP and MSKA & Associates. The filing encloses the audited standalone results, Regulation 52(4) disclosures, an audit opinion declaration, and Ind AS supplementary information. Net profit after tax for the year is partly legible in the OCR text (figure appears as 12,822 in one column and 55,598 in another, units not clearly printed), so the exact figures cannot be confirmed from these pages. The board meeting ran from 11:30 A.M. to 4:40 P.M. (IST), and the results are also hosted on the company's website. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 02 Apr 2026 | credit rating Rating | Star Health And Allied Insurance Company Limited has informed the Exchange about Credit RatingAI summaryCare Ratings Limited has reaffirmed the issuer rating of AA+ Stable for the Company. Care Ratings Limited has reaffirmed the rating of AA Stable for the Company's subordinate debt. The disclosure is made under Regulations 30 and 55 of the SEBI (LODR) Regulations, 2015. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Feb 2026 | transcript Results | Star Health and Allied Insurance Company Limited has informed the Exchange about transcript of Earnings Call dated January 29, 2026AI summaryStar Health and Allied Insurance filed the transcript of its Q3 and 9M FY2026 earnings call held on January 29, 2026. Management said Q3 FY2026 GWP (N basis) rose 23% year-on-year to Rs. 5,047 crore, and IND AS PAT rose from Rs. 87 crore to Rs. 449 crore. Management said Q3 FY2026 combined ratio improved to 98.9% from 102.1%, and 9M FY2026 IND AS underwriting profit was Rs. 20 crore versus a loss of Rs. 227 crore in 9M FY2025. Management said 9M FY2026 GWP rose 16% to Rs. 13,856 crore, IND AS PAT rose 87% to Rs. 966 crore, and retail health market share was 31.3%. Management said 9M FY2026 investment yield was 9.6% and claims settled totalled more than 2 million claims amounting to Rs. 8,900 crore. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jan 2026 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed a revised earnings call presentation for Q3 and 9M FY2026 (quarter and nine months ended December 31, 2025), hosted on its website, following a January 28, 2026 letter on the investor presentation. 9M FY26 profit after tax (IND AS) was INR 966 crore versus INR 516 crore in 9M FY25; combined ratio was 99.8% versus 102.1%; expense ratio was 29.8% versus 30.8%. 9M FY26 gross written premium (without 1/n) was INR 13,856 crore versus INR 11,947 crore, a 16% increase per the presentation's figures. Retail health market share was 31% in 9M FY26 versus 33% in 9M FY25, per GI Council data cited in the presentation; retail GWP was INR 13,170 crore versus INR 10,934 crore. Management's own commentary in the presentation is limited to data and KPI labels, so no direct management statements on outlook were identified. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2026 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed an earnings call presentation for Q3 and 9M FY2026 (quarter and nine months ended December 31, 2025), to be made to investors and analysts on January 29, 2026 at 8.30 A.M. IST. 9M FY26 profit after tax (IND AS) was INR 966 crore versus INR 516 crore in 9M FY25; combined ratio (IND AS) was 99.8% versus 102.1%; expense ratio was 29.8% versus 30.8%. 9M FY26 gross written premium (without 1/n) was INR 13,856 crore versus INR 11,947 crore in 9M FY25, a 16% rise on the printed figures; retail health GWP was INR 13,170 crore versus INR 10,934 crore, with retail health market share of 31% in 9M FY26 versus 33% in 9M FY25 per GI Council data. Persistency (renewal ratio) was 95% and the solvency ratio was 2.14x, as shown in the presentation. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2026 | board outcome Legal, Results | Star Health and Allied Insurance Company Limited has submitted to the Stock Exchange, the standalone unaudited financial results for the quarter and nine months ended December 31, 2025.AI summaryBoard meeting outcome dated January 28, 2026: the Board approved the unaudited standalone financial results for the quarter and nine months ended December 31, 2025, with a Limited Audit Review Report from joint statutory auditors T R Chadha & Co LLP and MSKA & Associates. The Board approved reclassification of two promoter group entities, Ebono Private Limited and GS E-commerce Private Limited, from the Promoter/Promoter group category to the Public category, each holding Nil shareholding, subject to approval of the stock exchanges and members. The meeting began at 12:00 Noon (IST) and concluded at 05:40 P.M. (IST). The financial figures (revenue, profit) are in the annexures and are not stated in the pages provided. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Nov 2025 | transcript Guidance, Legal, Results | STARHEALTH: Star Health and Allied Insurance Company Limited has informed the Exchange about Transcript of call dated October 29,2025.AI summaryStar Health filed the transcript of its Q2 and H1 FY2026 earnings call held on October 29, 2025. Management reported H1 FY2026 IFRS PAT of Rs. 518 crore (up 21% YoY) and Q2 FY2026 PAT of Rs. 79 crore (vs Rs. 124 crore), with Q2 impacted by an MTM loss of Rs. 122 crore pre-tax. Management reported H1 FY2026 combined ratio of 100.3% and Q2 net incurred claim ratio of 71.8% (vs 73.7%), and retail health GWP up about 17% to Rs. 8,332 crore in H1. Management said fresh business in October grew about 50% after the GST exemption on retail health indemnity policies, and that intermediary commission will be inclusive of GST from October 1. Management said it expects the gap between IGAAP and IFRS results to keep widening with business growth. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Oct 2025 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed its investor presentation for the Q2 and H1 FY2026 earnings call, to be held on October 29, 2025 at 8.30 A.M. IST, for the quarter and half year ended September 30, 2025. H1 FY26 IND AS profit after tax was Rs 518 crore, up from Rs 428 crore in H1 FY25; IND AS combined ratio was 100.3% versus 102.1%. H1 FY26 IND AS gross written premium was Rs 8,029 crore (Rs 8,809 crore without 1/n basis), against Rs 7,847 crore in H1 FY25 on the same without 1/n basis. Retail health gross written premium (without 1/n) was Rs 8,332 crore, up 17% from Rs 7,120 crore in H1 FY25, with retail health market share at 32%. Presentation reports a Renewal Ratio of 94%, overall NPS of 61, and grievances per 10,000 policies of 1.2 in H1 FY26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Oct 2025 | results Results | Star Health and Allied Insurance Company Limited has informed the exchange about Integrated filing for the period ended September 30,2025.AI summaryStar Health and Allied Insurance filed its integrated financial filing for the quarter and half year ended September 30, 2025, dated October 28, 2025, with BSE and NSE. The filing includes unaudited financial results (Annexure 1) with figures stated in lakhs, reviewed by statutory auditors MSKA & Associates and T R Chadha & Co LLP, who reported no matters that cause them to believe the statement contains material misstatement. The auditors noted that IBNR, IBNER and premium deficiency reserve as at September 30, 2025 were certified by the Appointed Actuary, and their conclusion is not modified on this point. The filing is also hosted on the company's website, www.starhealth.in. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Oct 2025 | board outcome Results | Star Healthand Allied Insurance Company Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.AI summaryStar Health and Allied Insurance Company Limited's board met on October 28, 2025 and approved the unaudited standalone financial results for the quarter and half year ended September 30, 2025. The results were reviewed by joint statutory auditors T R Chadha & Co LLP and MSKA & Associates, who issued a limited review report with an unmodified conclusion. The board meeting commenced at 12:00 Noon (IST) and concluded at 5:55 P.M. (IST). The results statement itself (Annexure 1) is partly illegible in the scanned pages, so specific revenue and profit figures could not be reliably stated. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2025 | transcript Guidance, Management change, Results | Star Health And Allied Insurance Company Limited has informed the Exchange about TranscriptAI summaryStar Health and Allied Insurance filed the transcript of its Q1 FY2026 earnings conference call held on July 30, 2025. Management reported Q1 FY2026 gross written premium of INR 3,936 crores (13% growth over the previous quarter, on N basis) and retail health GWP of INR 3,667 crores (up 18%). Management reported IFRS PAT of INR 438 crores, against INR 304 crores in Q1 FY2025, and a combined ratio of 99.6% versus 99.2%. Management said it expects loss ratios to improve over time as price corrections flow through, and announced Rajeev Kher as the new Board Chairperson, with COO Amitabh Jain and CMO Himanshu Walia proposed as Executive Directors, subject to regulatory approvals. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jul 2025 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed its Q1 FY2026 earnings call investor presentation, for the quarter ended June 30, 2025, to be made to investors and analysts on July 30, 2025 at 8.30 A.M. IST. Q1 FY26 PAT (IND AS) was INR 438 crore versus INR 304 crore in Q1 FY25; GWP (without 1/n) was INR 3,936 crore versus INR 3,476 crore. Q1 FY26 IND AS combined ratio was 99.6% versus 99.2%, and expense ratio was 30.1% versus 31.1%. Q1 FY26 retail health market share was 33% versus 31% in Q1 FY25 per GI Council data; retail GWP was INR 3,707 crore versus INR 3,139 crore (+18%). Return on equity (non-annualised) was 4.9% versus 3.8%. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jul 2025 | results Results | Star Health and Allied Insurance Co Ltd has informed the exchange about integrated filing financials for the quarter ended June 30,2025.AI summaryStar Health and Allied Insurance filed its integrated financial filing for the quarter ended June 30, 2025, with Annexure 1 containing the unaudited financial results, dated July 29, 2025. The Board approved the unaudited results at its meeting held on July 29, 2025, and the statutory auditors (MSKA & Associates and T R Chadha & Co LLP) issued a limited review report with no modification. The OCR text of the results table is partly garbled; the printed gross premium figure for the quarter appears as 3,47,592 (in INR thousand, as printed) and profit after tax as 26,252 (as printed). The filing does not include management commentary or outlook. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jul 2025 | board outcome Legal, Management change, Results | Star Health And Allied Insurance Company Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.AI summaryStar Health and Allied Insurance Company Limited filed the outcome of its board meeting held on July 29, 2025, including unaudited standalone financial results for the quarter ended June 30, 2025, with a limited review report from its joint statutory auditors. Board approved appointment of Ms. Princey Mehra as Chief Compliance Officer and Key Managerial Personnel effective September 1, 2025, under IRDAI Corporate Governance Regulations 2024. Board approved issuing a postal ballot notice to members seeking approval for remuneration of Mr. Rajeev Kher (Non-Executive Independent Director and Chairperson), remuneration of Mr. Anand Roy (Managing Director & CEO) for FY 2026, appointment of Mr. Himanshu Walia and Mr. Amitabh Jain as Whole-time Directors with FY 2026 remuneration, and a note on a share-based employee benefits statement. The filing does not state the revenue or profit figures from the quarterly results. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 May 2025 | presentation Capex, Legal | Star Health and Allied Insurance Company Limited has informed the Exchange about presentation on Star Flexi.AI summaryStar Health and Allied Insurance filed, under Regulation 30 of the SEBI LODR, a presentation titled "Super Star upgraded with the launch of Star Flexi" dated May 17, 2025. The presentation describes Star Flexi, a set of new add-on covers for the Super Star base health product, organised into curated packages named Essential, Preferred and Secure. Packages differ in sum insured (Essential ₹5/7.5/10 lacs; Preferred and Secure ₹7.5 to ₹100 lacs), locations (Essential Zone B/C excluding certain states; Preferred and Secure PAN India) and features such as room rent and pre/post hospitalisation cover. A disclaimer states the package names are marketing descriptors under the filed base product (UIN SHAHLIP25036V012425) and add-on (UIN SHAHLIA26040V012526), not separate products. The presentation's final slide references "Star Health Financial Performance FY25" but the pages provided contain no figures for it. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 12 May 2025 | board outcome Management change | Star Health And Allied Insurance Company Limited has informed the Exchange regarding Outcome of Board Meeting held on May 12, 2025.AI summaryBoard of Star Health and Allied Insurance Company Limited, meeting held May 12, 2025, approved appointment of Mr. Himanshu Walia (Chief Marketing Officer) as Whole-time Director and KMP for five years, effective from the date of IRDAI approval, subject to member and IRDAI approval. Board approved appointment of Mr. Amitabh Jain (Chief Operating Officer) as Whole-time Director and KMP for five years, effective from the date of IRDAI approval, subject to member and IRDAI approval. Board changed the effective date of appointment of Mr. Prashant Kalaver as Chief Risk Officer to May 19, 2025. The board meeting commenced at 11:15 A.M. (IST) and concluded at 11:27 A.M. (IST). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 May 2025 | transcript Guidance, Results | Star Health and Allied Insurance Company Limited has informed the Exchange about transcript of earning call dated April 30,2025.AI summaryStar Health and Allied Insurance filed the transcript of its Q4 and FY2025 earnings call held on April 30, 2025. Management said FY2025 combined ratio was 101.1% (97.3% in FY2024) and claim ratio was 70.7% (66.5% in FY2024), with PAT of Rs.787 crore versus Rs.1,103 crore in FY2024. Management said overall GWP grew 15% and fresh retail GWP grew 25% in FY2025; ROE for FY2025 was 9.5%, and solvency was 2.21 times against a regulatory requirement of 1.5 times. Management said it strengthened claim reserves in Q4 and described the GI Council common empanelment initiative as showing substantial progress. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Apr 2025 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed a revised Q4 & FY2025 earnings call presentation, correcting colour-coding of the Retail and Group Claims Ratio figures that had been interchanged in the earlier filing dated April 29, 2025. FY25 GWP (without 1/n) was INR 17,553 crore, up 15% from INR 15,254 crore in FY24; reported-basis GWP was INR 16,781 crore. FY25 profit after tax was INR 646 crore (IGAAP) versus INR 845 crore in FY24; IFRS PAT was INR 787 crore versus INR 1,103 crore. FY25 combined ratio (without 1/n) was 100.2% versus 96.7% in FY24; renewal ratio was 97% versus 98.4%. Retail ICR was 65.8% in FY24 and 68.8% in FY25; Group ICR was 77.3% in FY24 and 89.8% in FY25. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Apr 2025 | board outcome Management change, Results | Star Health And Allied Insurance Company Limited has informed the Exchange regarding Outcome of Board Meeting held on April 29, 2025.AI summaryBoard of Star Health and Allied Insurance Company Limited, meeting held April 29, 2025, approved audited standalone financial results for the quarter and year ended March 31, 2025, with unmodified auditor opinion from joint statutory auditors T R Chadha & Co LLP and MSKA & Associates. Board appointed Mr. Prashant Kalaver as Chief Risk Officer and Key Managerial Personnel with effect from May 12, 2025. Board appointed Mr. Rajeev Kher, Independent Director, as Chairperson of the Board, subject to IRDAI approval. The meeting commenced at 11:00 A.M. and concluded at 6:15 P.M. (IST). The scanned results tables are largely garbled, so specific profit and revenue figures could not be reliably read. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Apr 2025 | results Results | Star Health and Allied Insurance Company Limited has informed the exchange about Integrated filing financial dated April 29,2025.AI summaryStar Health and Allied Insurance filed its integrated financial filing for the quarter and year ended March 31, 2025, dated April 29, 2025, with BSE and NSE. The filing includes the auditors' report (MSKA & Associates and TR Chadha & Co LLP) on the audited financial results, which gives an unmodified opinion. The results table includes lines for income from investments, commission and brokerage (FY figures of 2,24,072 and 1,85,964), and appropriations including dividend. The OCR text of the results table is partly garbled, so the individual profit and dividend figures cannot be reliably read. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2025 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed its investor presentation for the Q4 and FY2025 earnings call, to be held on April 30, 2025 at 8.30 A.M. IST. FY25 gross written premium (without 1/n) was INR 17,553 crore, up 15% from INR 15,254 crore in FY24; reported-basis GWP was INR 16,781 crore, up 10%. FY25 profit after tax was INR 646 crore (IGAAP) versus INR 845 crore in FY24; IFRS PAT was INR 787 crore versus INR 1,103 crore. FY25 combined ratio (without 1/n) was 100.2% versus 96.7% in FY24; retail health renewal premium ratio was 97%. The presentation states that IFRS results are not mandated by the sectoral regulator and are special purpose statements prepared with support from an independent consultant. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2025 | board outcome Management change, Results | Star Health And Allied Insurance Company Limited has informed the Exchange regarding Outcome of Board Meeting held on April 29, 2025.AI summaryOutcome of the April 29, 2025 Board meeting of Star Health and Allied Insurance Company Limited, filed under SEBI LODR Regulations 30, 33, 51, 52. The Board approved audited standalone financial results for the quarter and year ended March 31, 2025, with unmodified audit opinion from joint statutory auditors T R Chadha & Co LLP and MSKA & Associates. The Board appointed Mr. Prashant Kalaver as Chief Risk Officer and Key Managerial Personnel with effect from May 12, 2025. The Board appointed Mr. Rajeev Kher, Independent Director, as Chairperson of the Board, subject to IRDAI approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 31 Jan 2025 | transcript Guidance, Results | Star Health And Allied Insurance Company Limited has informed the Exchange about TranscriptAI summaryStar Health and Allied Insurance filed the transcript of its Q3 & 9M FY2025 earnings call held on January 29, 2025. Management said 9M FY25 GWP grew 16% on a basis with the 1/N framework, and fresh GWP grew 27% without it; retail health GWP grew 14%, with 32.2% market share. Management reported 9M FY25 PAT of Rs. 645 crore, PBT of Rs. 862 crore, combined ratio of 101.8% (101.3% without 1/N) and non-annualized ROE of 9.7%. On the Q&A, management said Q3 GWP growth was 13.7% and that the expense ratio increase reflects lower NWP from the 1/N accounting, with no like-to-like increase. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Jan 2025 | presentation Dividend / buy-back, Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed a revised earnings call presentation for Q3 and 9MFY25, correcting the Retail Health Renewal Premium Ratio for the 9 months ended December 31, 2023 to 98.2% (previously shown otherwise). 9MFY25 gross written premium (GWP) was INR 11,643 crore, up 13% period-on-period, and profit after tax was INR 645 crore, with non-annualized ROE of 9.7%. Combined ratio for 9MFY25 was 101.8% (101.3% without the 1/n accounting change), and underwriting loss was INR 104 crore, with the company citing the mandated 1/n accounting for long-term products effective October 1, 2024. Management highlighted a retail health market share of 32.2% in the retail health insurance market, 910 branches, 761k agents and a solvency ratio of 2.22x (premium based). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2025 | presentation Results | Star Health And Allied Insurance Company Limited has informed the Exchange about Investor PresentationAI summaryStar Health and Allied Insurance filed an earnings call presentation for Q3 and 9MFY25 (quarter and nine months ended December 31, 2024), to be made to investors and analysts on January 29, 2025 at 8.30 A.M. IST. 9MFY25 GWP was INR 11,643 crore (up 13% year on year); profit after tax was INR 645 crore; non-annualized ROE was 9.7%. 9MFY25 combined ratio was 101.8% (101.3% without the 1/n accounting change, effective October 1, 2024, for long-term products as mandated by IRDAI). 9MFY25 underwriting loss was INR 104 crore versus a profit of INR 180 crore in 9MFY24; investment yield was 8.3% annualized. Retail health market share was 32.2% and the agency force stood at 760 thousand in 9MFY25. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2025 | results Results | Integrated filing (Financial) of the Company for the quarterand nine months ended December 31, 2024AI summaryStar Health and Allied Insurance filed its integrated financial filing for the quarter and nine months ended December 31, 2024, dated January 28, 2025, under SEBI and IRDAI requirements. The unaudited financial results were approved by the Board at its meeting held on January 28, 2025, and were subject to a limited review by the statutory auditors, MSKA & Associates and T R Chadha & Co LLP, who reported no material misstatement. The auditors relied on the Appointed Actuary's certification of IBNR, IBNER and premium deficiency reserve as at December 31, 2024. The page text is partly garbled by OCR, so the detailed income and profit figures could not be reliably read and are not stated here. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2025 | results Results | Star Health And Allied Insurance Company Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.AI summaryBoard of Star Health and Allied Insurance Company Limited approved the un-audited standalone financial results for the quarter and nine months ended December 31, 2024 at its meeting held on January 28, 2025. The results were accompanied by a Limited Audit Review Report from joint statutory auditors T R Chadha & Co LLP and MSKA & Associates, with no modification in conclusion. The board meeting commenced at 11:30 A.M. (IST) and concluded at 17:55 Hrs. (IST). The detailed results statement (Annexure 1) is OCR-garbled in the provided pages, so specific revenue and profit figures could not be reliably stated. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.